• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺腺癌中TRP相关基因分子亚型的系统分析、鉴定及预后预测

Systematic Analysis and Identification of Molecular Subtypes of TRP-Related Genes and Prognosis Prediction in Lung Adenocarcinoma.

作者信息

Guo Yang, Liu Ning

机构信息

Shenyang Tenth People's Hospital (Shenyang Chest Hospital), No 11 Beihai Street, Dadong District, Shenyang 110044, Liaoning, China.

出版信息

J Oncol. 2022 Aug 31;2022:5388283. doi: 10.1155/2022/5388283. eCollection 2022.

DOI:10.1155/2022/5388283
PMID:36090899
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9452946/
Abstract

BACKGROUND

Transient receptor potential channel (TRP) is a superfamily of nonselective cation channels, which is a member of calcium ion channels with a vital role in different calcium ion signal transduction pathways. TRP channel expression is often changed in the tumor, although the role of TRP proteins in lung cancer is unknown.

METHODS

Molecular Signatures Database (MsigDB) provided the TRP gene set. Univariate Cox regression analysis was performed on The Cancer Genome Atlas Lung Adenocarcinoma (TCGA-LUAD) data collection set employing the coxph function of R package survival to find prognosis-related genes. The R package ConsumusClusterPlus was employed for doing the consistency cluster analysis of TCGA-LUAD samples according to the prognosis-related TRP gene. The R-package limma was utilized for investigating the differential expression of TRP subtypes. According to the differentially expressed genes between subtypes, the least absolute shrinkage and selection operator (LASSO) regression was employed to find the major genes and develop the risk model. CIBERPORT algorithm, R package maftools, gene set variation analysis (GSVA), and pRRophetic of R-package were employed for measuring the proportion of immune cells among subtypes, genomic mutation difference, pathway enrichment score, and drug sensitivity analysis.

RESULTS

A total of 15 TRP-related genes associated with the prognosis of lung adenocarcinoma were found. According to the expression value of 15 genes, lung adenocarcinoma can be sorted into two subcategories. The prognosis of cluster1 is considerably better in comparison with that of cluster2. There were 123 differentially expressed genes between C1 and C2 subtypes, including 6 up- and 117 downregulated genes. There were major variations in the tumor microenvironment between C1 and C2 subtypes. The proportion of CD8 T cells in the C1 subtype was considerably enhanced in comparison with that in the C2 subtype. We further discovered 123 differentially expressed genes among subtypes, and 8 key genes were obtained at the end. The risk score (RS) model developed by the 8-gene signature had good strength in the TCGA validation set, overall set, and Gene Expression Omnibus (GEO) external dataset. There were major variations in immune checkpoint gene expression, patient sensitivity to immunotherapeutic drugs, immune infiltration, and genomic mutations between high and low groups on the basis of RS.

CONCLUSIONS

The risk model developed on the basis of TRP-related genes can help in predicting the prognosis of patients suffering from lung adenocarcinoma and guide immunotherapy.

摘要

背景

瞬时受体电位通道(TRP)是一类非选择性阳离子通道超家族,是钙离子通道的成员之一,在不同的钙离子信号转导途径中起重要作用。TRP通道表达在肿瘤中常发生改变,尽管TRP蛋白在肺癌中的作用尚不清楚。

方法

分子特征数据库(MsigDB)提供TRP基因集。利用R包survival的coxph函数对癌症基因组图谱肺腺癌(TCGA-LUAD)数据集进行单变量Cox回归分析,以寻找预后相关基因。使用R包ConsumusClusterPlus根据预后相关的TRP基因对TCGA-LUAD样本进行一致性聚类分析。利用R包limma研究TRP亚型的差异表达。根据亚型间的差异表达基因,采用最小绝对收缩和选择算子(LASSO)回归寻找主要基因并建立风险模型。采用CIBERPORT算法、R包maftools、基因集变异分析(GSVA)和R包的pRRophetic来测量亚型间免疫细胞比例、基因组突变差异、通路富集分数和药物敏感性分析。

结果

共发现15个与肺腺癌预后相关的TRP相关基因。根据15个基因的表达值,肺腺癌可分为两个亚类。与cluster2相比,cluster1的预后明显更好。C1和C2亚型之间有123个差异表达基因,包括6个上调基因和117个下调基因。C1和C2亚型之间的肿瘤微环境存在主要差异。与C2亚型相比,C1亚型中CD8 T细胞的比例显著增加。我们进一步发现亚型间有123个差异表达基因,最终获得8个关键基因。由8基因特征建立的风险评分(RS)模型在TCGA验证集、总体集和基因表达综合数据库(GEO)外部数据集中具有良好的预测能力。基于RS的高低分组在免疫检查点基因表达、患者对免疫治疗药物的敏感性、免疫浸润和基因组突变方面存在主要差异。

结论

基于TRP相关基因建立的风险模型有助于预测肺腺癌患者的预后并指导免疫治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8828/9452946/df3bca4fe796/JO2022-5388283.015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8828/9452946/605cbee69fe8/JO2022-5388283.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8828/9452946/5e31939c99ed/JO2022-5388283.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8828/9452946/5ea5163ef5d5/JO2022-5388283.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8828/9452946/ed4a781de544/JO2022-5388283.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8828/9452946/c36b9799ed8b/JO2022-5388283.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8828/9452946/a84c35da7454/JO2022-5388283.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8828/9452946/79d27dabe209/JO2022-5388283.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8828/9452946/26031a7bf1b4/JO2022-5388283.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8828/9452946/19be316cded7/JO2022-5388283.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8828/9452946/af3acb703dd3/JO2022-5388283.010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8828/9452946/8b1a193194a3/JO2022-5388283.011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8828/9452946/1eccb851a291/JO2022-5388283.012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8828/9452946/a925abd340e0/JO2022-5388283.013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8828/9452946/0fa4561b1a14/JO2022-5388283.014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8828/9452946/df3bca4fe796/JO2022-5388283.015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8828/9452946/605cbee69fe8/JO2022-5388283.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8828/9452946/5e31939c99ed/JO2022-5388283.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8828/9452946/5ea5163ef5d5/JO2022-5388283.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8828/9452946/ed4a781de544/JO2022-5388283.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8828/9452946/c36b9799ed8b/JO2022-5388283.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8828/9452946/a84c35da7454/JO2022-5388283.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8828/9452946/79d27dabe209/JO2022-5388283.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8828/9452946/26031a7bf1b4/JO2022-5388283.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8828/9452946/19be316cded7/JO2022-5388283.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8828/9452946/af3acb703dd3/JO2022-5388283.010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8828/9452946/8b1a193194a3/JO2022-5388283.011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8828/9452946/1eccb851a291/JO2022-5388283.012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8828/9452946/a925abd340e0/JO2022-5388283.013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8828/9452946/0fa4561b1a14/JO2022-5388283.014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8828/9452946/df3bca4fe796/JO2022-5388283.015.jpg

相似文献

1
Systematic Analysis and Identification of Molecular Subtypes of TRP-Related Genes and Prognosis Prediction in Lung Adenocarcinoma.肺腺癌中TRP相关基因分子亚型的系统分析、鉴定及预后预测
J Oncol. 2022 Aug 31;2022:5388283. doi: 10.1155/2022/5388283. eCollection 2022.
2
Anoikis-related subtype and prognosis analyses based on bioinformatics, and an expression verification of ANGPTL4 based on experiments of lung adenocarcinoma.基于生物信息学的失巢凋亡相关亚型及预后分析,以及基于肺腺癌实验的ANGPTL4表达验证。
J Thorac Dis. 2024 Aug 31;16(8):5361-5378. doi: 10.21037/jtd-24-1123. Epub 2024 Aug 28.
3
Glucose metabolism-based signature predicts prognosis and immunotherapy strategies for colon adenocarcinoma.基于葡萄糖代谢的特征可预测结肠腺癌的预后和免疫治疗策略。
J Gene Med. 2024 Jan;26(1):e3620. doi: 10.1002/jgm.3620. Epub 2023 Nov 16.
4
Integrating multiple machine learning algorithms for prognostic prediction of gastric cancer based on immune-related lncRNAs.基于免疫相关长链非编码RNA整合多种机器学习算法用于胃癌预后预测
Front Genet. 2023 Apr 4;14:1106724. doi: 10.3389/fgene.2023.1106724. eCollection 2023.
5
Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis.基于机器学习的肺腺癌新型基因特征识别,预测免疫治疗和预后。
Front Immunol. 2023 Jul 31;14:1177847. doi: 10.3389/fimmu.2023.1177847. eCollection 2023.
6
Identification of N7-methylguanosine related signature for prognosis and immunotherapy efficacy prediction in lung adenocarcinoma.鉴定用于预测肺腺癌预后和免疫治疗疗效的N7-甲基鸟苷相关特征
Front Med (Lausanne). 2022 Aug 24;9:962972. doi: 10.3389/fmed.2022.962972. eCollection 2022.
7
Identification of 5-Gene Signature Improves Lung Adenocarcinoma Prognostic Stratification Based on Differential Expression Invasion Genes of Molecular Subtypes.基于分子亚型差异表达侵袭基因的 5 基因特征识别可改善肺腺癌的预后分层。
Biomed Res Int. 2020 Dec 31;2020:8832739. doi: 10.1155/2020/8832739. eCollection 2020.
8
A transient receptor potential channel-related model based on machine learning for evaluating tumor microenvironment and immunotherapeutic strategies in acute myeloid leukemia.基于机器学习的瞬时受体电位通道相关模型用于评估急性髓系白血病的肿瘤微环境和免疫治疗策略。
Front Immunol. 2022 Dec 16;13:1040661. doi: 10.3389/fimmu.2022.1040661. eCollection 2022.
9
Establishment of lung adenocarcinoma classification and risk model based on necroptosis-related genes.基于坏死性凋亡相关基因的肺腺癌分类及风险模型的建立
Front Genet. 2022 Nov 14;13:1037011. doi: 10.3389/fgene.2022.1037011. eCollection 2022.
10
Prognostic Value and Genome Signature of m6A/m5C Regulated Genes in Early-Stage Lung Adenocarcinoma.m6A/m5C 调控基因在早期肺腺癌中的预后价值和基因组特征。
Int J Mol Sci. 2023 Mar 30;24(7):6520. doi: 10.3390/ijms24076520.

引用本文的文献

1
Development and validation of transient receptor potential channel-related signature for predicting prognosis in patients with lung adenocarcinoma.用于预测肺腺癌患者预后的瞬时受体电位通道相关特征的开发与验证
Oncol Lett. 2025 Jul 29;30(4):464. doi: 10.3892/ol.2025.15210. eCollection 2025 Oct.
2
Multi-omics analysis reveals associations between gut microbiota and host transcriptome in colon cancer patients.多组学分析揭示了结肠癌患者肠道微生物群与宿主转录组之间的关联。
mSystems. 2025 Mar 18;10(3):e0080524. doi: 10.1128/msystems.00805-24. Epub 2025 Feb 27.
3
Application of combined ablation and immunotherapy in NSCLC and liver cancer: Current status and future prospects.

本文引用的文献

1
The Pan-Cancer Landscape of Crosstalk Between TRP Family and Tumour Microenvironment Relevant to Prognosis and Immunotherapy Response.跨癌种 TRP 家族与肿瘤微环境相互作用与预后和免疫治疗反应相关的全景图。
Front Immunol. 2022 Apr 13;13:837665. doi: 10.3389/fimmu.2022.837665. eCollection 2022.
2
Functional Transient Receptor Potential Ankyrin 1 and Vanilloid 1 Ion Channels Are Overexpressed in Human Oral Squamous Cell Carcinoma.功能性瞬时受体电位锚蛋白 1 和香草素 1 离子通道在人口腔鳞状细胞癌中过表达。
Int J Mol Sci. 2022 Feb 8;23(3):1921. doi: 10.3390/ijms23031921.
3
Chordin-like 1 is a novel prognostic biomarker and correlative with immune cell infiltration in lung adenocarcinoma.
联合消融与免疫疗法在非小细胞肺癌和肝癌中的应用:现状与未来展望
Heliyon. 2024 Aug 14;10(16):e36388. doi: 10.1016/j.heliyon.2024.e36388. eCollection 2024 Aug 30.
4
Integrated bulk and single-cell RNA sequencing identifies an aneuploidy-based gene signature to predict sensitivity of lung adenocarcinoma to traditional chemotherapy drugs and patients' prognosis.整合 bulk 和单细胞 RNA 测序,确定了基于非整倍体的基因特征,可预测肺腺癌对传统化疗药物的敏感性和患者的预后。
PeerJ. 2024 Jun 24;12:e17545. doi: 10.7717/peerj.17545. eCollection 2024.
Chordin-like 1 是肺腺癌的一种新型预后生物标志物,与免疫细胞浸润相关。
Aging (Albany NY). 2022 Jan 12;14(1):389-409. doi: 10.18632/aging.203814.
4
TRP channels in health and disease at a glance.TRP 通道在健康和疾病中的作用一目了然。
J Cell Sci. 2021 Jul 1;134(13). doi: 10.1242/jcs.258372. Epub 2021 Jul 13.
5
Alterations of the Platelet Proteome in Lung Cancer: Accelerated F13A1 and ER Processing as New Actors in Hypercoagulability.肺癌中血小板蛋白质组的改变:F13A1和内质网加工加速作为高凝状态的新因素
Cancers (Basel). 2021 May 8;13(9):2260. doi: 10.3390/cancers13092260.
6
Low expression of CHRDL1 and SPARCL1 predicts poor prognosis of lung adenocarcinoma based on comprehensive analysis and immunohistochemical validation.基于综合分析和免疫组化验证,CHRDL1和SPARCL1的低表达预示肺腺癌预后不良。
Cancer Cell Int. 2021 May 12;21(1):259. doi: 10.1186/s12935-021-01933-9.
7
Expression profiling of CPS1 in Correa's cascade and its association with gastric cancer prognosis.CPS1在科雷亚级联反应中的表达谱及其与胃癌预后的关联。
Oncol Lett. 2021 Jun;21(6):441. doi: 10.3892/ol.2021.12702. Epub 2021 Apr 2.
8
CYP4B1 is a prognostic biomarker and potential therapeutic target in lung adenocarcinoma.CYP4B1 是肺腺癌的预后生物标志物和潜在治疗靶点。
PLoS One. 2021 Feb 16;16(2):e0247020. doi: 10.1371/journal.pone.0247020. eCollection 2021.
9
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
10
Factor XIIIa inhibitors as potential novel drugs for venous thromboembolism.因子 XIIIa 抑制剂作为静脉血栓栓塞症的新型潜在药物。
Eur J Med Chem. 2020 Aug 15;200:112442. doi: 10.1016/j.ejmech.2020.112442. Epub 2020 May 18.